I was expecting very little price movement this mo
Post# of 36537
(Total Views: 307)
Posted On: 02/24/2021 11:26:58 AM
I was expecting very little price movement this morning. But there is room for improvement on the messaging.
Instead of saying:
"We...plan to submit the IND to the FDA as soon as the GMP production of the Ii-Key vaccine is completed in the coming weeks."
Just say:
"We are currently producing the vaccine needed for the Phase I/II trials and finalizing the IND application to the FDA."
There's nothing misleading there, but you haven't explicitly said "come back in a few weeks, there's nothing to see here".
And the reader is over-scienced up front. Grab people's attention with bullet points, then direct them with a link to a tailored web page specifically drilling down into those HLA details, etc.
That makes room for bullets like:
- We are concurrently producing trial batches for a separate Phase I/II trial which will be conducted in China under the guidance of the Chinese FDA.
Instead of saying:
"We...plan to submit the IND to the FDA as soon as the GMP production of the Ii-Key vaccine is completed in the coming weeks."
Just say:
"We are currently producing the vaccine needed for the Phase I/II trials and finalizing the IND application to the FDA."
There's nothing misleading there, but you haven't explicitly said "come back in a few weeks, there's nothing to see here".
And the reader is over-scienced up front. Grab people's attention with bullet points, then direct them with a link to a tailored web page specifically drilling down into those HLA details, etc.
That makes room for bullets like:
- We are concurrently producing trial batches for a separate Phase I/II trial which will be conducted in China under the guidance of the Chinese FDA.
(3)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼